- Home
- LOMA vs EMBC Comparison
LOMA vs EMBC Comparison
Compare LOMA & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOMA
- EMBC
- Stock Information
- Founded
- LOMA 1926
- EMBC 1924
- Country
- LOMA Argentina
- EMBC United States
- Employees
- LOMA N/A
- EMBC N/A
- Industry
- LOMA Building Materials
- EMBC Medical/Dental Instruments
- Sector
- LOMA Industrials
- EMBC Health Care
- Exchange
- LOMA Nasdaq
- EMBC Nasdaq
- Market Cap
- LOMA 916.1M
- EMBC 803.0M
- IPO Year
- LOMA 2017
- EMBC N/A
- Fundamental
- Price
- LOMA $11.34
- EMBC $13.37
- Analyst Decision
- LOMA Strong Buy
- EMBC Buy
- Analyst Count
- LOMA 2
- EMBC 2
- Target Price
- LOMA $15.00
- EMBC $18.50
- AVG Volume (30 Days)
- LOMA 906.8K
- EMBC 419.4K
- Earning Date
- LOMA 11-06-2025
- EMBC 11-25-2025
- Dividend Yield
- LOMA N/A
- EMBC 4.42%
- EPS Growth
- LOMA N/A
- EMBC 20.90
- EPS
- LOMA 0.06
- EMBC 1.62
- Revenue
- LOMA $464,306,268.00
- EMBC $1,080,400,000.00
- Revenue This Year
- LOMA $22.92
- EMBC N/A
- Revenue Next Year
- LOMA $25.84
- EMBC N/A
- P/E Ratio
- LOMA $185.32
- EMBC $8.38
- Revenue Growth
- LOMA N/A
- EMBC N/A
- 52 Week Low
- LOMA $7.04
- EMBC $9.20
- 52 Week High
- LOMA $14.17
- EMBC $21.48
- Technical
- Relative Strength Index (RSI)
- LOMA 61.48
- EMBC 42.41
- Support Level
- LOMA $10.74
- EMBC $13.61
- Resistance Level
- LOMA $12.01
- EMBC $14.81
- Average True Range (ATR)
- LOMA 0.69
- EMBC 0.70
- MACD
- LOMA -0.10
- EMBC -0.01
- Stochastic Oscillator
- LOMA 63.80
- EMBC 16.76
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.